Cable Hill Partners’s Lineage Cell Therapeutics LCTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q2 | – | Sell |
-10,000
| Closed | -$13K | – | 442 |
|
|
2019
Q1 | $13K | Buy |
10,000
+5,000
| +100% | +$6.5K | ﹤0.01% | 439 |
|
|
2018
Q4 | $5K | Sell |
5,000
-715
| -13% | -$715 | ﹤0.01% | 567 |
|
|
2018
Q3 | $11K | Hold |
5,715
| – | – | ﹤0.01% | 406 |
|
|
2018
Q2 | $10K | Hold |
5,715
| – | – | ﹤0.01% | 471 |
|
|
2018
Q1 | $12K | Buy |
5,715
+4,572
| +400% | +$9.6K | 0.01% | 437 |
|
|
2017
Q4 | $3K | Sell |
1,143
-2,286
| -67% | -$6K | ﹤0.01% | 822 |
|
|
2017
Q3 | $9K | Buy |
3,429
+2,286
| +200% | +$6K | ﹤0.01% | 604 |
|
|
2017
Q2 | $3K | Buy |
+1,143
| New | +$3K | ﹤0.01% | 639 |
|